Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion

✍ Scribed by Xi He; Leah M. Hesse; Suwagmani Hazarika; Gina Masse; Jerold S. Harmatz; David J. Greenblatt; Michael H. Court

• Book ID: 108642392
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 827 KB
• Volume: 68
• Category: Article
• ISSN: 0306-5251
• DOI: 10.1111/j.1365-2125.2009.03519.x